Layoff
Jan 2023Atomwise (the former name of Numerion Labs) laid off about 30% of staff during a strategic shift toward a narrower internal pipeline, according to Endpoints News.
SourceArtificial intelligence for drug discovery.
Company research
Public company, workplace, funding, and market signals
Updated Jul 30, 2026
Overview
Numerion Labs is an AI-native biotech company (formerly Atomwise) focused on small-molecule drug discovery. Its core platform combines COSMOS, APEX, and EXPO to search chemical space and generate/optimize novel drug-like molecules, with programs centered on immune and inflammatory diseases.
Primary product
AI-powered small-molecule drug discovery platform
Founded
2012
Headquarters
250 Sutter Street, Suite 650, San Francisco, CA 94108, United States
Team size
10-20
Work style
Flexible
Industry
Biotechnology Research
Sub-industry
AI-powered drug discovery
Offices
Open Positions
0 jobs at Numerion Labs
No open positions
Check back later for new openings